NUZ neurizon therapeutics limited

Ann: Neurizon Files IND Application to Support HEALEY ALS Trial, page-99

  1. 2,642 Posts.
    lightbulb Created with Sketch. 1911
    So survival is no longer a measure. Interesting considering MT latest reply to a question on portal says everything is about survival times according to FDA

    For convenience, with editing:

    PrimaryOutcome Measures

    1. Disease Progression

    Change in diseaseseverity as measured by the ALS Functional Rating Scale-Revised (ALSFRS-R)total score and survival.

    [Time Frame: 36 Weeks]


    SecondaryOutcome Measures

    1. Respiratory Function

    Change in respiratoryfunction over time as measured by Slow Vital Capacity (SVC).

    [Time Frame: 36 Weeks]

    1. Survival

    Comparison of rate ofoccurrence between groups.

    [Time Frame: 36 Weeks]

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.5¢
Change
0.005(2.94%)
Mkt cap ! $86.15M
Open High Low Value Volume
17.0¢ 18.5¢ 16.5¢ $91.76K 527.0K

Buyers (Bids)

No. Vol. Price($)
4 80407 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 31 1
View Market Depth
Last trade - 15.34pm 20/06/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.